down arrow

Arcellx, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US03940C1009
USD
68.45
-0.36 (-0.52%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Dynavax Technologies Corp.
Arrowhead Pharmaceuticals, Inc.
Intellia Therapeutics, Inc.
Alvotech
Beam Therapeutics, Inc.
Prothena Corp. Plc
Arcellx, Inc.
Nuvalent, Inc.
Denali Therapeutics, Inc.
Ventyx Biosciences, Inc.
Mirati Therapeutics, Inc.
Why is Arcellx, Inc. ?
1
The company has declared negative results for the last 2 consecutive quarters
  • The company has declared negative results in Dec 24 after 6 consecutive negative quarters
  • OPERATING CASH FLOW(Y) Lowest at USD -118.18 MM
  • PRE-TAX PROFIT(Q) At USD -52.74 MM has Fallen at -96.35%
  • NET PROFIT(Q) At USD -52.77 MM has Fallen at -94%
2
Risky - Negative EBITDA
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -18.35%, its profits have fallen by -221.4%
3
Underperformed the market in the last 1 year
  • Even though the market (S&P 500) has generated returns of 12.33% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -18.35% returns
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Arcellx, Inc. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Arcellx, Inc.
-22.79%
0.66
52.50%
S&P 500
13.22%
0.61
20.17%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-80.89%
EBIT Growth (5y)
14.71%
EBIT to Interest (avg)
-84.49
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-1.29
Sales to Capital Employed (avg)
0.19
Tax Ratio
1.29%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
531.09%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
9.00
EV to EBIT
-16.87
EV to EBITDA
-17.41
EV to Capital Employed
-26.98
EV to Sales
41.88
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-38.96%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company
DEBTORS TURNOVER RATIO(HY)

Highest at 17.53 times

-31What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at USD -118.18 MM

PRE-TAX PROFIT(Q)

At USD -52.74 MM has Fallen at -96.35%

NET PROFIT(Q)

At USD -52.77 MM has Fallen at -94%

NET SALES(Q)

Lowest at USD 7.55 MM

RAW MATERIAL COST(Y)

Grown by 17.89% (YoY

Here's what is working for Arcellx, Inc.
Debtors Turnover Ratio
Highest at 17.53 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Arcellx, Inc.
Net Sales
At USD 7.55 MM has Fallen at -72.41%
Year on Year (YoY)
MOJO Watch
Near term sales trend is extremely negative

Net Sales (USD MM)

Pre-Tax Profit
At USD -52.74 MM has Fallen at -96.35%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit
At USD -52.77 MM has Fallen at -94%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)

Operating Cash Flow
Lowest at USD -118.18 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Net Sales
Lowest at USD 7.55 MM and Fallen
In each period in the last five periods
MOJO Watch
Near term sales trend is very negative

Net Sales (USD MM)

Raw Material Cost
Grown by 17.89% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."